News

Article

EMA Sends Roche Findings to European Commission

EMA sends its results on Roche investigation of pharmacovigilance non-compliance to the European Commission.

The European Medicines Agency (EMA) has sent its findings from an inquiry into pharmacovigilance non-compliance by Roche Registration to the European Commission. The commission began an infringement procedure against Roche is October 2012 to investigate if the company had failed to comply with pharmacovigilance obligations. A 2012 inspection by the United Kingdom Medicines and Healthcare Products Regulatory Agency had discovered shortcomings in Roche’s pharmacovigilance processes, according to EMA.

EMA’s report summarizes the agency’s findings on the allegations. The European Commission will decide on further action after review the report.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey